SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-11-041558
Filing Date
2011-07-28
Accepted
2011-07-28 17:27:12
Documents
7
Period of Report
2011-07-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a11-23185_18k.htm 8-K 47573
2 EX-1.1 a11-23185_1ex1d1.htm EX-1.1 248483
3 EX-5.1 a11-23185_1ex5d1.htm EX-5.1 13430
4 EX-99.1 a11-23185_1ex99d1.htm EX-99.1 13436
5 EX-99.2 a11-23185_1ex99d2.htm EX-99.2 13784
6 GRAPHIC g231851mmi001.jpg GRAPHIC 5981
7 GRAPHIC g231851moi001.jpg GRAPHIC 5981
  Complete submission text file 0001104659-11-041558.txt   354698
Mailing Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 11994712
SIC: 2836 Biological Products, (No Diagnostic Substances)